Skip to main content
. 2011 Dec 13;27(4):979–986. doi: 10.3892/or.2011.1591

Figure 2.

Figure 2

Survival curves of patients. (A) The overall survival of NSCLC patients with BAG-positive or -negative expression (χ2 =4.032, P=0.045). (B) The time to progression of NSCLC patients with BAG-positive or -negative expression (χ2=7.243, P=0.007).